FDA Import Refusal AEK-9291931-3/50002/1 — NAVANA PHARMA
The FDA refused shipment AEK-9291931-3/50002/1 from NAVANA PHARMA (Bangladesh) on Jan 30, 2026. The refused product falls under Drugs and Biologics — ALOGLIPTIN BENZOATE (ANTI-DIABETIC). Cited charge: 75
Refusal details
- Date
- Jan 30, 2026
- Country
- Bangladesh
- Product Category
- Drugs and Biologics
- Product Code
- 61PCE65 ALOGLIPTIN BENZOATE (ANTI-DIABETIC)
- Charges
- 75